TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

Levi Hoste, Lisa Roels, Leslie Naesens, Victor Bosteels, Stijn Vanhee, Sam Dupont, Cedric Bosteels, Robin Browaeys, Niels Vandamme, Kevin Verstaen, Jana Roels, Karel F A Van Damme, Bastiaan Maes, Elisabeth De Leeuw, Jozefien Declercq, Helena Aegerter, Leen Seys, Ursula Smole, Sofie De Prijck, Manon Vanheerswynghels, Karlien Claes, Veronique Debacker, Gert Van Isterdael, Lynn Backers, Kathleen B M Claes, Paul Bastard, Emmanuelle Jouanguy, Shen-Ying Zhang, Gilles Mets, Joke Dehoorne, Kristof Vandekerckhove, Petra Schelstraete, Jef Willems, MIS-C Clinicians, Patrick Stordeur, Sophie Janssens, Rudi Beyaert, Yvan Saeys, Jean-Laurent Casanova, Bart N Lambrecht, Filomeen Haerynck, Simon J Tavernier
Author Information
  1. Levi Hoste: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  2. Lisa Roels: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  3. Leslie Naesens: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  4. Victor Bosteels: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  5. Stijn Vanhee: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  6. Sam Dupont: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  7. Cedric Bosteels: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  8. Robin Browaeys: Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  9. Niels Vandamme: Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  10. Kevin Verstaen: Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  11. Jana Roels: Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  12. Karel F A Van Damme: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  13. Bastiaan Maes: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  14. Elisabeth De Leeuw: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  15. Jozefien Declercq: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  16. Helena Aegerter: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  17. Leen Seys: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  18. Ursula Smole: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  19. Sofie De Prijck: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  20. Manon Vanheerswynghels: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  21. Karlien Claes: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  22. Veronique Debacker: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  23. Gert Van Isterdael: VIB Flow Core, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  24. Lynn Backers: Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University and Ghent University Hospital, Ghent, Belgium. ORCID
  25. Kathleen B M Claes: Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University and Ghent University Hospital, Ghent, Belgium. ORCID
  26. Paul Bastard: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. ORCID
  27. Emmanuelle Jouanguy: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. ORCID
  28. Shen-Ying Zhang: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. ORCID
  29. Gilles Mets: Department of Internal Medicine and Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium. ORCID
  30. Joke Dehoorne: Department of Internal Medicine and Pediatrics, Division of Pediatric Rheumatology, Ghent University Hospital, Ghent, Belgium. ORCID
  31. Kristof Vandekerckhove: Department of Internal Medicine and Pediatrics, Division of Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium. ORCID
  32. Petra Schelstraete: Department of Internal Medicine and Pediatrics, Division of Pediatric Pulmonology, Infectious Diseases and Inborn Errors of Immunity, Ghent University Hospital, Ghent, Belgium. ORCID
  33. Jef Willems: Department of Critical Care, Division of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium. ORCID
  34. Patrick Stordeur: Belgian National Reference Center for the Complement System, Laboratory of Immunology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium. ORCID
  35. Sophie Janssens: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  36. Rudi Beyaert: Center for Inflammation Research, Laboratory of Molecular Signal Transduction in Inflammation, VIB, Ghent, Belgium. ORCID
  37. Yvan Saeys: Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium. ORCID
  38. Jean-Laurent Casanova: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France. ORCID
  39. Bart N Lambrecht: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium. ORCID
  40. Filomeen Haerynck: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID
  41. Simon J Tavernier: Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University, Ghent, Belgium. ORCID

Abstract

In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared MIS-C immunopathology with severe COVID-19 in adults. MIS-C does not result in pneumocyte damage but is associated with vascular endotheliitis and gastrointestinal epithelial injury. In MIS-C, the cytokine release syndrome is characterized by IFNγ and not type I interferon. Persistence of patrolling monocytes differentiates MIS-C from severe COVID-19, which is dominated by HLA-DRlo classical monocytes. IFNγ levels correlate with granzyme B production in CD16+ NK cells and TIM3 expression on CD38+/HLA-DR+ T cells. Single-cell TCR profiling reveals a skewed TCRβ repertoire enriched for TRBV11-2 and a superantigenic signature in TIM3+/CD38+/HLA-DR+ T cells. Using NicheNet, we confirm IFNγ as a central cytokine in the communication between TIM3+/CD38+/HLA-DR+ T cells, CD16+ NK cells, and patrolling monocytes. Normalization of IFNγ, loss of TIM3, quiescence of CD16+ NK cells, and contraction of patrolling monocytes upon clinical resolution highlight their potential role in MIS-C immunopathogenesis.

References

  1. N Engl J Med. 2020 May 7;382(19):1811-1822 [PMID: 32374962]
  2. J Clin Invest. 2021 May 17;131(10): [PMID: 33705359]
  3. JAMA. 2020 Jul 21;324(3):259-269 [PMID: 32511692]
  4. J Clin Invest. 2020 Nov 2;130(11):5967-5975 [PMID: 32730233]
  5. Sci Rep. 2018 Feb 8;8(1):2603 [PMID: 29422518]
  6. N Engl J Med. 2020 Jul 23;383(4):334-346 [PMID: 32598831]
  7. Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435 [PMID: 32199469]
  8. Heart Fail Rev. 2014 Mar;19(2):227-36 [PMID: 23589353]
  9. Nature. 2014 Apr 17;508(7496):397-401 [PMID: 24509713]
  10. Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25254-25262 [PMID: 32989130]
  11. J Clin Invest. 1989 Feb;83(2):724-7 [PMID: 2492310]
  12. N Engl J Med. 2021 Jul 1;385(1):11-22 [PMID: 34133854]
  13. Front Immunol. 2018 Jan 24;9:23 [PMID: 29416538]
  14. Front Immunol. 2021 Mar 12;12:635615 [PMID: 33777025]
  15. Acta Paediatr. 2020 Jun;109(6):1088-1095 [PMID: 32202343]
  16. iScience. 2021 Nov 19;24(11):103215 [PMID: 34632327]
  17. Nat Rev Immunol. 2013 Mar;13(3):176-89 [PMID: 23411799]
  18. Infect Immun. 2001 Nov;69(11):7169-72 [PMID: 11598096]
  19. Nat Methods. 2020 Feb;17(2):159-162 [PMID: 31819264]
  20. J Allergy Clin Immunol. 2020 Jul;146(1):119-127.e4 [PMID: 32360286]
  21. Crit Care Med. 2011 Mar;39(3):480-8 [PMID: 21220996]
  22. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426 [PMID: 32271728]
  23. PLoS One. 2011;6(9):e24441 [PMID: 21915328]
  24. J Allergy Clin Immunol. 2019 Jun;143(6):2215-2226.e7 [PMID: 30578871]
  25. Nat Immunol. 2021 Jan;22(1):25-31 [PMID: 33154590]
  26. Science. 2020 Oct 23;370(6515): [PMID: 32972995]
  27. Immunity. 2008 Sep 19;29(3):391-403 [PMID: 18703361]
  28. Ann Rheum Dis. 2017 Jan;76(1):166-172 [PMID: 27296321]
  29. J Infect Dis. 2021 Jul 2;224(1):70-80 [PMID: 33822097]
  30. Lancet. 2020 May 23;395(10237):1607-1608 [PMID: 32386565]
  31. Front Immunol. 2020 Jun 26;11:1311 [PMID: 32676080]
  32. Sci Immunol. 2020 Jun 26;5(48): [PMID: 32591408]
  33. N Engl J Med. 2020 Dec 3;383(23):2255-2273 [PMID: 33264547]
  34. Cell. 2021 Jun 24;184(13):3573-3587.e29 [PMID: 34062119]
  35. Sci Immunol. 2021 May 13;6(59): [PMID: 34446527]
  36. Clin Immunol. 2008 Jan;126(1):67-80 [PMID: 17964857]
  37. Nat Commun. 2021 Apr 6;12(1):2055 [PMID: 33824342]
  38. Cell. 2020 Nov 12;183(4):968-981.e7 [PMID: 32966765]
  39. Pediatr Pulmonol. 2021 May;56(5):837-848 [PMID: 33428826]
  40. J Clin Invest. 2021 Jul 15;131(14): [PMID: 34032635]
  41. Sci Immunol. 2021 May 25;6(59): [PMID: 34035116]
  42. J Infect Dis. 1983 Mar;147(3):391-8 [PMID: 6833789]
  43. Paediatr Respir Rev. 2021 Jun;38:51-57 [PMID: 32891582]
  44. Ann Rheum Dis. 2020 Aug;79(8):999-1006 [PMID: 32527868]
  45. Science. 2020 Oct 23;370(6515): [PMID: 32972996]
  46. Eur J Haematol. 2005 Jan;74(1):6-10 [PMID: 15613100]
  47. J Immunol. 2015 Mar 1;194(5):2358-68 [PMID: 25637019]
  48. Med. 2021 Sep 10;2(9):1072-1092.e7 [PMID: 34414385]
  49. Am J Pathol. 2007 Aug;171(2):463-72 [PMID: 17556594]
  50. Trends Microbiol. 2020 Dec;28(12):956-958 [PMID: 33190685]
  51. Sci Immunol. 2021 Mar 2;6(57): [PMID: 33653907]
  52. Clin Infect Dis. 2016 Aug 15;63(4):478-86 [PMID: 27105747]
  53. Lancet. 2020 Jun 6;395(10239):1771-1778 [PMID: 32410760]
  54. Immunity. 2021 May 11;54(5):1083-1095.e7 [PMID: 33891889]
  55. Nat Rev Immunol. 2020 Jun;20(6):339-341 [PMID: 32317716]
  56. JAMA. 2021 Mar 2;325(9):855-864 [PMID: 33523115]
  57. Immunity. 2018 Oct 16;49(4):725-739.e6 [PMID: 30314758]
  58. Trials. 2020 Jun 03;21(1):468 [PMID: 32493441]
  59. Hum Mutat. 2017 Jul;38(7):788-797 [PMID: 28419628]
  60. JAMA. 2021 Mar 16;325(11):1074-1087 [PMID: 33625505]
  61. Infect Immun. 2001 Mar;69(3):1256-64 [PMID: 11179286]
  62. Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15 [PMID: 16456142]
  63. N Engl J Med. 2020 Jul 23;383(4):347-358 [PMID: 32598830]
  64. Nat Med. 2020 Nov;26(11):1701-1707 [PMID: 32812012]
  65. Lancet Child Adolesc Health. 2021 May;5(5):323-331 [PMID: 33711293]
  66. Eur J Pediatr. 2021 Jul;180(7):2019-2034 [PMID: 33599835]
  67. Nat Rev Immunol. 2020 Mar;20(3):173-185 [PMID: 31676858]
  68. Blood. 2004 Aug 1;104(3):735-43 [PMID: 15069016]
  69. Cell. 2020 Nov 12;183(4):982-995.e14 [PMID: 32991843]
  70. World J Gastroenterol. 2010 Nov 14;16(42):5272-9 [PMID: 21072889]
  71. EClinicalMedicine. 2021 May;35:100850 [PMID: 33937731]
  72. Lancet Respir Med. 2020 Dec;8(12):1233-1244 [PMID: 33075298]
  73. Arthritis Rheumatol. 2014 Sep;66(9):2613-20 [PMID: 24782338]
  74. Front Immunol. 2021 Mar 26;12:654587 [PMID: 33841438]
  75. Immunity. 2010 Mar 26;32(3):392-402 [PMID: 20303298]
  76. J Clin Invest. 2019 Nov 1;129(11):4691-4707 [PMID: 31566580]
  77. Med. 2020 Dec 18;1(1):14-20 [PMID: 33363283]
  78. EClinicalMedicine. 2020 Sep;26:100527 [PMID: 32923992]
  79. Clin Biochem. 2003 Oct;36(7):529-35 [PMID: 14563446]
  80. Nat Commun. 2020 Nov 30;11(1):6077 [PMID: 33257685]
  81. PLoS One. 2011 Feb 03;6(2):e16764 [PMID: 21304813]
  82. Lancet Child Adolesc Health. 2020 Sep;4(9):653-661 [PMID: 32593339]
  83. J Clin Invest. 2021 Mar 15;131(6): [PMID: 33497356]
  84. J Pediatr. 2012 Jun;160(6):984-90.e1 [PMID: 22226576]
  85. J Pediatr. 2020 Nov;226:45-54.e1 [PMID: 32768466]
  86. Biomedicines. 2022 Jun 06;10(6): [PMID: 35740360]
  87. Sci Immunol. 2018 Jan 19;3(19): [PMID: 29352091]
  88. Gastroenterology. 2020 Oct;159(4):1571-1574.e2 [PMID: 32505742]
  89. J Exp Med. 2021 Jun 7;218(6): [PMID: 33904890]
  90. JAMA Pediatr. 2020 Sep 01;174(9):882-889 [PMID: 32320004]
  91. Nat Med. 2020 Apr;26(4):502-505 [PMID: 32284613]
  92. Nat Commun. 2019 Oct 21;10(1):4779 [PMID: 31636267]
  93. Genes Immun. 2021 Oct;22(5-6):289-303 [PMID: 33875817]
  94. N Engl J Med. 2021 Jul 1;385(1):23-34 [PMID: 34133855]
  95. Nat Immunol. 2020 Sep;21(9):1107-1118 [PMID: 32788748]

Grants

  1. /Vlaams Instituut voor Biotechnologie
  2. /Ghent University
  3. /Fonds Wetenschappelijk Onderzoek

MeSH Term

Adolescent
Alveolar Epithelial Cells
B-Lymphocytes
Blood Vessels
COVID-19
Cell Proliferation
Child
Cohort Studies
Complement Activation
Cytokines
Enterocytes
Female
Hepatitis A Virus Cellular Receptor 2
Humans
Immunity, Humoral
Inflammation
Interferon Type I
Interferon-gamma
Interleukin-15
Killer Cells, Natural
Lymphocyte Activation
Male
Monocytes
Receptors, Antigen, T-Cell
Receptors, IgG
SARS-CoV-2
Superantigens
Systemic Inflammatory Response Syndrome
T-Lymphocytes

Chemicals

Cytokines
Hepatitis A Virus Cellular Receptor 2
Interferon Type I
Interleukin-15
Receptors, Antigen, T-Cell
Receptors, IgG
Superantigens
Interferon-gamma